Myriad Genetics Q4 Revenues Grow 4 Percent
The firm reported total revenues of $160.8 million in the quarter, all from molecular diagnostic test sales, but came in below analysts' consensus estimate due to COVID-19 headwinds.
Source: 360dx.com
Page 9 - Bracanalysis Cdx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bracanalysis Cdx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bracanalysis Cdx Today - Breaking & Trending Today
Myriad Genetics to Release Fourth-Quarter 2021 Financial Results on February 24, 2022
SALT LAKE CITY, Feb. 16, 2022 -- Myriad Genetics, Inc., a leader in genetic testing and precision medicine, will hold its 2021 fourth-quarter earnings conference call on Thursday, February 24,... | February 16, 2022
Source: marketscreener.com
Myriad Genetics to Present at Two Upcoming Healthcare
SALT LAKE CITY, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will be...
Source: globenewswire.com
Myriad Genetics to Present at Two Upcoming Healthcare Conferences
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
People in the News: New Appointments at Singular Genomics, Molecular Stethoscope, Veracyte, More
Singular Genomics: Elaine Mardis Singular Genomics has added Elaine Mardis to its board of directors. Since 2016, Mardis has served as co-executive director of the Institute of Genomic Medicine at Nationwide Children's Hospital, and holds the Steve and Cindy Rasmussen endowed chair in genomic…
Source: genomeweb.com